Seeking Alpha

Nektar Therapeutics (NKTR) agrees to sell royalties for its Cimzia and Mircera drugs to Royalty...

Nektar Therapeutics (NKTR) agrees to sell royalties for its Cimzia and Mircera drugs to Royalty Pharma for $124M. The company plans to use the net proceeds of the transaction towards the repayment of its $215M in convertible debt. Shares are currently under a trading halt.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)